Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.05% | $1.43B | €347.07B | 30.57% | 76 Outperform | |
| AstraZeneca | 1.39% | $972.98M | £209.38B | 28.56% | 80 Outperform | |
| Roche Holding AG | 1.39% | $972.37M | CHF256.01B | 38.07% | 73 Outperform | |
| Novartis AG | 1.27% | $883.90M | CHF204.56B | 21.14% | 80 Outperform | |
| HSBC Holdings | 1.27% | $882.84M | HK$1.99T | 46.73% | 80 Outperform | |
| SAP SE | 1.25% | $875.04M | €241.18B | -14.07% | 66 Neutral | |
| Nestlé SA | 1.25% | $873.92M | CHF198.25B | 17.61% | 71 Outperform | |
| Siemens | 1.05% | $729.05M | €186.01B | 23.12% | 74 Outperform | |
| Shell (UK) | 1.00% | $700.36M | £149.91B | 8.82% | 73 Outperform | |
| Toyota Motor | 1.00% | $700.20M | ¥43.40T | 25.16% | 80 Outperform |